Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery

被引：0
|
作者：
Erickson, Nicholas J. [1 ]
Stavarache, Mihaela [2 ]
Tekedereli, Ibrahim [1 ]
Kaplitt, Michael G. [2 ]
Markert, James M. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA
[2] Weill Cornell Med, Dept Neurol Surg, Lab Mol Neurosurg, New York, NY USA
来源：
WORLD NEUROSURGERY | 2025年 / 194卷
关键词：
Magnetic resonance-guided focused ultrasound; Magnetic Malignant glioma; Oncolytic viral therapy; INTENSITY FOCUSED ULTRASOUND; BRAIN-BARRIER DISRUPTION; LIPOSOMAL DOXORUBICIN; RIBONUCLEOTIDE REDUCTASE; GLIOBLASTOMA-MULTIFORME; ENHANCED DELIVERY; TUMOR BARRIER; VIRUS; REPLICATION; VIROTHERAPY;
D O I：
10.1016/j.wneu.2024.123595
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors present a comprehensive review on the history and development of oncolytic herpes simplex viral therapies for malignant glioma with a focus on mechanisms of delivery in prior and ongoing clinical trials. This review highlights the advancements made with regard to delivering these therapies to a highly complex immunologic environment in the setting of the blood-brain and blood-tumor barrier in a safe and effective manner.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Advances in antitumour therapy with oncolytic herpes simplex virus combinations
    Qi, Xuejiao
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [32] Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer
    Kohno, SI
    Luo, CH
    Goshima, F
    Nishiyama, Y
    Sata, T
    Ono, Y
    UROLOGY, 2005, 66 (05) : 1116 - 1121
  • [33] Engineered herpes simplex virus oncolytic therapy kills both tumor cells and glioma progenitor cells in a pediatric high-grade glioma
    Friedman, Gregory
    Bharara, Suman
    Langford, Catherine
    Coleman, Jennifer
    Gillespie, Yancey
    NEURO-ONCOLOGY, 2008, 10 (03) : 508 - 509
  • [34] Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
    Jean, Didier
    Delaunay, Tiphaine
    Meiller, Clement
    Boisgerault, Nicolas
    Grard, Marion
    Caruso, Stefano
    Blanquart, Christophe
    Felley-Bosco, Emanuela
    Bennouna, Jaafar
    Tangy, Frederic
    Gregoire, Marc
    Fonteneau, Jean-Francois
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E112 - E115
  • [35] Systemic delivery of fusogenic oncolytic herpes simplex viruses for advanced prostate cancer
    Nakamori, M
    Fu, XP
    Pettaway, CA
    Zhang, XL
    MOLECULAR THERAPY, 2003, 7 (05) : S293 - S293
  • [36] Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
    Menotti, Laura
    Avitabile, Elisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 26
  • [37] Oncolytic virus therapy using genetically engineered herpes simplex viruses
    Todo T.
    Human Cell, 2002, 15 (3) : 151 - 159
  • [38] Development of herpes simplex viral vectors for cancer therapy
    Martuza, RL
    CANCER GENE THERAPY, 1999, 6 (06) : S9 - S10
  • [39] Oncolytic herpes simplex virus and immunotherapy
    Wenqing Ma
    Hongbin He
    Hongmei Wang
    BMC Immunology, 19
  • [40] Promises of oncolytic viral therapy for adult and children with brain glioma
    Patino-Garcia, Ana
    Alonso, Marta M.
    Perez-Larraya, Jaime Gallego
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (06) : 529 - 535
12345